Dhananjay Taumar | Pharmaceutical Sciences | Best Academic Researcher Award

Published on | Editorial Board by World Top Scientists

Best Academic Researcher Award

Dhananjay Taumar –  IIMT University Meerut

 Dhananjay Taumar
Affiliation IIMT University Meerut
Country India
Scopus ID 58785853500
Documents 14
Citations 16
h-index 1
Subject Area Pharmaceutical Sciences
Event Name World Top Scientist Awards
ORCID 0009-0008-8967-4672

This article presents an academic overview of the research profile of Dhananjay Taumar, affiliated with IIMT University Meerut, in relation to the Best Academic Researcher Award. The summary follows a neutral encyclopedic style and highlights publicly available scholarly indicators including publication output, citations, research interests, and persistent researcher identifiers. The information is intended for academic reference and reflects recognized research indexing practices.[1]

Abstract

Dhananjay Taumar’s documented research activity is indexed through internationally recognized scholarly databases and reflects contributions within pharmaceutical sciences. Available metrics indicate fourteen indexed documents together with citation activity and an h-index that collectively provide measurable evidence of research dissemination. Such indicators are commonly used for institutional evaluation, research visibility, and academic recognition while being interpreted alongside qualitative scholarly assessment.[2]

Keywords

Pharmaceutical Sciences, Scopus, ORCID, Academic Research, Citation Analysis, Scholarly Publishing, Research Metrics, Research Evaluation.

Introduction

Academic awards frequently consider research productivity, publication quality, citation influence, and sustained scholarly engagement. International indexing platforms improve transparency by providing standardized author profiles and publication records that assist institutions and award committees in evidence-based evaluation. Persistent researcher identifiers further enhance attribution and long-term discoverability.[3]

Research Profile

The available profile indicates that Dhananjay Taumar is affiliated with IIMT University Meerut and conducts research within pharmaceutical sciences. The author’s Scopus profile and ORCID identifier contribute to reliable scholarly identification across publishers and indexing systems. These resources support research integrity, author disambiguation, and consistent academic reporting.[1]

Research Contributions

Research contributions in pharmaceutical sciences commonly include experimental studies, reviews, collaborative investigations, and scientific communication that advance understanding within the discipline. Indexed publications enable peer verification while citation records demonstrate continuing engagement by the scholarly community. These characteristics form important components of academic assessment.[4]

Publications

The publication record of Dhananjay Taumar reflects a consistent research focus on pharmaceutical sciences, nanotechnology-based drug delivery, neuropharmacology, and modern therapeutic strategies. Recent publications indexed through ORCID and Scopus include studies on silica-based nanocarriers, gene delivery, antimicrobial peptides, inflammatory disorders, and precision medicine. These scholarly works demonstrate interdisciplinary collaboration with researchers from multiple institutions while addressing contemporary healthcare challenges through evidence-based pharmaceutical research.[2]

Research Impact

The research impact of Dhananjay Taumar may be evaluated using internationally accepted scholarly indicators such as indexed publications, citation count, author profile visibility, and persistent digital identifiers. Available records indicate active publication in peer-reviewed journals together with measurable citation activity that contributes to the visibility of his scientific work. The combination of ORCID registration, Scopus indexing, and DOI-linked publications supports transparency, accessibility, and long-term discoverability of research outputs within the global academic community.[3]

Award Suitability

Recognition through academic awards generally considers research quality, publication consistency, citation performance, institutional affiliation, and scholarly contribution to the advancement of knowledge. Based on publicly available academic records, Dhananjay Taumar possesses verifiable research credentials supported by indexed publications and internationally recognized researcher identifiers. The final determination of eligibility for the World Top Scientist Awards remains subject to the official evaluation process and independent selection criteria established by the award organizing committee.[4]

Conclusion

The academic profile presented in this article summarizes publicly available information relating to Dhananjay Taumar’s scholarly activities, institutional affiliation, publication record, and research identifiers. The available evidence indicates ongoing contributions within pharmaceutical sciences through peer-reviewed publications and collaborative research initiatives. This information serves as an objective academic overview intended for reference purposes and supports transparent documentation of scholarly achievements within internationally recognized research databases.[5]

References

  1. Taumar, D., Singh, A. P., Sharma, H., Gohri, S., & Chaudhary, V. (2026). Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02131-8
  2. Taumar, D., Singh, A. P., Sharma, H., Shamim, Gohri, S., & Chaudhary, V. (2026). Mechanistic and safety evaluation of standardized traditional Chinese medicine formulations and their bioactive constituents in ICD-11-classified inflammatory skin diseases: A structured narrative review. https://doi.org/10.1016/j.prmcm.2026.100827
  3. Taumar, D., Kumar, A., Singh, A. P., & Dhama, N. (2026).
    ROS-responsive baicalin hydrogel from Scutellaria baicalensis for targeted modulation of cutaneous inflammation: Mechanistic insights and translational perspectives. https://doi.org/10.1016/j.prmcm.2026.100807
  4. Shamim, Singh, A. P., Sharma, H., Gohri, S., Taumar, D., & Chaudhary, V. (2026). Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson’s disease. https://doi.org/10.1093/jpp/rgag052
  5. Kumar, S., Taumar, D., Gaikwad, S., More, A., Nema, V., & Mukherjee, A. (2024).
    Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection. https://doi.org/10.1007/s13346-023-01492-8

Panagiota Koutsimani | Neuropsychology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Panagiota Koutsimani | Neuropsychology | Best Researcher Award

Adjunt Lecturer | University of Western Macedonia | Greece

Dr. Panagiota Koutsimani is a cognitive neuropsychologist specializing in burnout, cognitive functioning, and mental health. She holds a PhD in Cognitive Psychology from the University of Macedonia and is currently a postdoctoral researcher at Aristotle University of Thessaloniki. Her research has significantly contributed to understanding the relationships between burnout, depression, and anxiety, notably through her widely cited meta-analysis published in Frontiers in Psychology. She has also investigated cognitive performance in non-clinical burnout populations, highlighting the role of family support as a protective factor. Her work employs rigorous methodologies, including longitudinal studies and meta-analyses, reflecting a strong commitment to advancing psychological research. In addition to her research, Dr. Koutsimani has extensive teaching and dissertation supervision experience, mentoring emerging researchers in both cognitive and neuropsychology fields. According to her Google Scholar profile, total citations 1903, since 2020 citations 1854, h-index 8, i10-index 7.

Profile: Scopus | Google Scholar

Featured Publications

1. P. Koutsimani, A. Montgomery, and K. Georganta, “The relationship between burnout, depression, and anxiety: A systematic review and meta-analysis,” Frontiers in Psychology, vol. 10, p. 429219, 2019.

2. A. Kariou, P. Koutsimani, A. Montgomery, and O. Lainidi, “Emotional labor and burnout among teachers: A systematic review,” International Journal of Environmental Research and Public Health, vol. 18, no. 23, p. 12760, 2021.

3. P. Koutsimani, A. Montgomery, E. Masoura, and E. Panagopoulou, “Burnout and cognitive performance,” International Journal of Environmental Research and Public Health, vol. 18, no. 4, p. 2145, 2021.

4. P. Koutsimani, A. Montgomery, and K. Georganta, “The relationship between burnout, depression, and anxiety: A systematic review and meta-analysis,” Frontiers in Psychology, vol. 10, p. 284, 2019.

5. P. Koutsimani and A. Montgomery, “A two-wave study on the associations of burnout with depression and anxiety: The mediating and moderating role of perceived family support,” Psychological Reports, vol. 126, no. 1, pp. 220–245, 2023.

Abdullah Al Nahian | Data Analyst | Best Research Article Award

Published on | Editorial Board by World Top Scientists

Mr. Abdullah Al Nahian | Data Analyst | Best Research Article Award

Healthcare Data Analyst at Children’s Clinic of Michigan, United States

Mr. Abdullah Al Nahian is a dedicated professional and researcher with a strong background in data analytics, computer science, and information systems. His career spans diverse roles including data analyst, network engineer, software developer, and project coordinator, where he has consistently demonstrated expertise in data analysis, system optimization, and project management. Academically, he holds advanced education in information studies and computer science, complemented by certifications in project management, cybersecurity, and database systems. His research contributions focus on impactful areas such as predictive modeling for healthcare outcomes, machine learning applications in cancer stage classification, and neural network-based recognition systems, which have been published in reputable scientific platforms. Abdullah’s work bridges technical innovation with practical applications, particularly in healthcare and information technology, underscoring his ability to contribute solutions to real-world challenges. His combination of academic rigor, technical expertise, and professional experience highlights him as a promising researcher and thought leader in his field.

Professional Profile 

Google Scholar

Education

Mr. Abdullah Al Nahian has built a strong academic foundation that supports his career in technology and research. He earned his Bachelor of Science in Computer Science and Engineering from the University of Liberal Arts Bangladesh, where he developed core knowledge in programming, software development, and system design. To further strengthen his expertise, he pursued a Master of Science in Information Studies at Trine University, Detroit, with a focus on data analytics, information systems, and applied research. His academic journey has been complemented by professional certifications, including Project Management Professional (PMP), Advanced Database, and Cybersecurity, which add specialized knowledge to his technical profile. This combination of formal education and certifications demonstrates his commitment to continuous learning and skill development. By bridging theoretical understanding with practical applications, his educational background provides a strong base for his professional roles and impactful research contributions in data science, healthcare analytics, and machine learning.

Experience

Mr. Abdullah Al Nahian brings extensive professional experience across multiple domains of information technology, data analysis, and project management. Currently working as a Data Analyst at the Children’s Clinic of Michigan, he specializes in gathering, securing, and analyzing healthcare data to improve patient outcomes and operational efficiency. His previous roles include Assistant Coordinator at Polock Group BD, Network Engineer and Assistant Manager at Agni Systems Ltd., and Software Developer at NKSoft BD. Across these roles, he developed expertise in network engineering, customer support, ERP systems, project coordination, and administrative leadership. His career began with web development, gradually expanding to more advanced responsibilities involving data-driven decision-making, system monitoring, and organizational leadership. This progression highlights his adaptability and growth across technical and managerial domains. Additionally, his volunteer work as an IT Specialist further demonstrates his dedication to using technology for organizational improvement and staff empowerment. Collectively, his diverse experience reflects both technical mastery and leadership capability.

Research Focus

Mr. Abdullah Al Nahian’s research focuses on the intersection of data science, healthcare, and machine learning, reflecting both technical innovation and practical significance. His work includes developing predictive models to optimize healthcare outcomes, leveraging data-driven insights to improve patient care and resource management. He has also co-authored research on cancer stage classification using numerical biomarker data, showcasing the role of artificial intelligence in advancing medical diagnosis. Beyond healthcare, his contributions extend to neural network-powered recognition systems, such as automated license plate detection, and in-depth studies on project management and visualization techniques. His approach emphasizes applying computational methods to solve real-world problems, combining theoretical rigor with practical utility. Through his publications in recognized scientific platforms, he demonstrates a commitment to advancing knowledge in applied machine learning, data analytics, and information systems. His research is notable for addressing global challenges in healthcare and technology, bridging academic inquiry with societal impact.

Award and Honor

Mr. Abdullah Al Nahian has established himself as a promising researcher whose academic and professional achievements make him a strong candidate for recognition. His research contributions, published in respected scientific journals and platforms, reflect innovation and applicability in critical domains such as healthcare analytics, artificial intelligence, and project management. Co-authoring multiple peer-reviewed publications within a short period demonstrates his dedication to scholarly excellence and collaborative research. His academic journey, complemented by certifications in project management and cybersecurity, highlights his commitment to professional growth and expertise. In professional settings, he has consistently been recognized for leadership, technical problem-solving, and delivering solutions that improve organizational performance. While his portfolio primarily emphasizes research and professional contributions, his trajectory indicates strong potential for continued recognition through awards that honor innovation, interdisciplinary impact, and societal value. His blend of academic, research, and professional accomplishments positions him as a valuable contributor deserving of future honors.

Publications Top Notes

  • Title: Optimizing Healthcare Outcomes through Data-Driven Predictive Modeling
    Authors: MNM Sunny, MBH Saki, A Al Nahian, SW Ahmed, MN Shorif, J Atayeva, …
    Year: 2024
    Citations: 33

  • Title: Project Management and Visualization Techniques A Details Study
    Authors: MNM Sunny, MBH Sakil, A Al
    Year: 2024
    Citations: 24

  • Title: Neural Network-Powered License Plate Recognition System Design
    Authors: S Hasan, MNM Sunny, A Al Nahian, M Yasin
    Year: 2024
    Citations: 19

  • Title: Classification of Cancer Stages Using Machine Learning on Numerical Biomarker Data
    Authors: MNM Sunny, MM Amin, MH Akter, KMS Hossain, A Al Nahian, J Atayeva
    Year: 2024
    Citations: 3

  • Title: Optimizing Prescription Practices Using AI-Powered Drug Substitution Models to Reduce Unnecessary Healthcare Expenditures in Outpatient Settings
    Authors: A Al Nahian, S Samia, MTM Hussan, F Mahmud, MNM Sunny, SW Ahmed, …
    Year: 2025

  • Title: A Critical Review of Network Management Tools and Technologies in the Digital Age
    Authors: AAN Zakia Sultnana Munmun, Md Minhajul Amin, K M Shihab Hossain
    Year: 2024

Conclusion

Mr. Abdullah Al Nahian’s research portfolio demonstrates a consistent focus on applying data-driven approaches and machine learning techniques to solve critical challenges in healthcare, project management, and technology systems. His publications reflect both academic rigor and practical relevance, particularly in predictive healthcare modeling, cancer diagnosis, and AI-powered optimization solutions. The diversity of his work, ranging from network technologies to medical applications, highlights his ability to bridge interdisciplinary fields and contribute meaningful innovations. With multiple citations already attributed to his recent publications, his research is gaining recognition and impact in the academic community. His role as co-author in several high-quality studies also emphasizes strong collaboration skills and commitment to advancing collective knowledge. Overall, his contributions position him as a capable and promising researcher whose work holds significant value for both academic advancement and real-world problem-solving.

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683